Julian Howell

We founded PharmaKrysto to bring a new prescription treatment for cystinuria to the market. Our novel, patented molecules have demonstrated effectiveness in two animal models, and cleared preliminary safety testing. With a Lead and Back-Up molecules we are now ready to start our IND and Phase 1/1b programme.